| Nanostructured lipid carriers: Promising drug delivery systems for future clinics A Beloqui, MÁ Solinís, A Rodríguez-Gascón, AJ Almeida, V Préat Nanomedicine: Nanotechnology, biology and medicine 12 (1), 143-161, 2016 | 648 | 2016 |
| Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier A Beloqui, MÁ Solinís, AR Gascón, A del Pozo-Rodríguez, A des Rieux, ... Journal of Controlled Release 166 (2), 115-123, 2013 | 216 | 2013 |
| Augmented renal clearance in critically ill patients: a systematic review I Bilbao-Meseguer, A Rodriguez-Gascon, H Barrasa, A Isla, MÁ Solinís Clinical pharmacokinetics 57, 1107-1121, 2018 | 179 | 2018 |
| Nanomedicines to deliver mRNA: state of the art and future perspectives I Gómez-Aguado, J Rodríguez-Castejón, M Vicente-Pascual, ... Nanomaterials 10 (2), 364, 2020 | 172 | 2020 |
| Short-and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy A del Pozo-Rodríguez, MA Solinís, AR Gascón, JL Pedraz European Journal of Pharmaceutics and Biopharmaceutics 71 (2), 181-189, 2009 | 168 | 2009 |
| Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis A Beloqui, R Coco, M Alhouayek, MÁ Solinís, A Rodríguez-Gascón, ... International journal of pharmaceutics 454 (2), 775-783, 2013 | 145 | 2013 |
| Application of lipid nanoparticles to ocular drug delivery L Battaglia, L Serpe, F Foglietta, E Muntoni, M Gallarate, ... Expert opinion on drug delivery 13 (12), 1743-1757, 2016 | 140 | 2016 |
| A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors A del Pozo-Rodríguez, S Pujals, D Delgado, MA Solinís, AR Gascón, ... Journal of Controlled Release 133 (1), 52-59, 2009 | 131 | 2009 |
| Solid lipid nanoparticles: formulation factors affecting cell transfection capacity A del Pozo-Rodríguez, D Delgado, MA Solinís, AR Gascón, JL Pedraz International journal of pharmaceutics 339 (1-2), 261-268, 2007 | 130 | 2007 |
| Applications of lipid nanoparticles in gene therapy A del Pozo-Rodriguez, MÁ Solinís, A Rodríguez-Gascón European Journal of Pharmaceutics and Biopharmaceutics 109, 184-193, 2016 | 126 | 2016 |
| Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells A del Pozo-Rodriguez, D Delgado, MA Solinis, AR Gascón, JL Pedraz International journal of pharmaceutics 360 (1-2), 177-183, 2008 | 122 | 2008 |
| Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway D Delgado, A del Pozo-Rodríguez, MÁ Solinís, A Rodríguez-Gascón European Journal of Pharmaceutics and Biopharmaceutics 79 (3), 495-502, 2011 | 117 | 2011 |
| A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases PS Apaolaza, D Delgado, A del Pozo-Rodriguez, AR Gascón, MÁ Solinís International journal of pharmaceutics 465 (1-2), 413-426, 2014 | 112 | 2014 |
| Treatment of ocular disorders by gene therapy MÁ Solinís, A del Pozo-Rodríguez, PS Apaolaza, A Rodríguez-Gascón European Journal of Pharmaceutics and Biopharmaceutics 95, 331-342, 2015 | 107 | 2015 |
| Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration A del Pozo-Rodríguez, D Delgado, MÁ Solinís, JL Pedraz, E Echevarría, ... International journal of pharmaceutics 385 (1-2), 157-162, 2010 | 107 | 2010 |
| Dextran–protamine–solid lipid nanoparticles as a non-viral vector for gene therapy: In vitro characterization and in vivo transfection after intravenous administration to mice D Delgado, AR Gascón, A del Pozo-Rodríguez, E Echevarría, ... International journal of pharmaceutics 425 (1-2), 35-43, 2012 | 105 | 2012 |
| Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles PS Apaolaza, A del Pozo-Rodríguez, MA Solinís, JM Rodríguez, ... Biomaterials 90, 40-49, 2016 | 103 | 2016 |
| Lipid nanoparticles as drug/gene delivery systems to the retina A del Pozo-Rodríguez, D Delgado, AR Gascón, MÁ Solinís Journal of Ocular Pharmacology and Therapeutics 29 (2), 173-188, 2013 | 97 | 2013 |
| Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis D Delgado, A del Pozo-Rodríguez, MÁ Solinís, M Avilés-Triqueros, ... Human gene therapy 23 (4), 345-355, 2012 | 96 | 2012 |
| Dextran–protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs A Beloqui, MÁ Solinís, A des Rieux, V Préat, A Rodríguez-Gascón International journal of pharmaceutics 468 (1-2), 105-111, 2014 | 95 | 2014 |
Alicia Rodríguez-GascónFull Professor, Faculty of Pharmacy, Universidad del País Vasco UPV/EHUVerified email at ehu.eus
